MGMT and cancer: In agreement with this, we found that hypermethylation on the UBA1 promoter in cancer was rare (Supplementary Fig. S1E), in contrast to the reported (31–33) frequent hypermethylation on the MGMT promoter (Supplementary Fig. S1E).